Rapid inhibition of MAPK signaling and anti-proliferation effect via JAK/STAT signaling by interferon-α in hepatocellular carcinoma cell lines

Sangro, 1998, Prognosis of hepatocellular carcinoma in relation to treatment: a multivariate analysis of 178 patients from a single European institution, Surgery, 124, 575, 10.1016/S0039-6060(98)70105-9 Tada, 1998, Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-alpha in human hepatoma cell lines, Int. J. Oncol., 13, 1207 Shyu, 2000, Direct growth suppressive activity of interferon-alpha and -gamma on human gastric cancer cells, J. Surg. Oncol., 75, 122, 10.1002/1096-9098(200010)75:2<122::AID-JSO9>3.0.CO;2-4 Yoshida, 2002, Interferon therapy prolonged life expectancy among chronic hepatitis C patients, Gastroenterology, 123, 483, 10.1053/gast.2002.34785 Ikeda, 2000, Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer, Hepatology, 32, 228, 10.1053/jhep.2000.9409 Wang, 2003, Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice, J. Gastrointest. Surg., 7, 587, 10.1016/S1091-255X(03)00072-6 Leung, 1999, Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma, Clin. Cancer Res., 5, 1676 Kaneko, 2002, Combination chemotherapy for advanced hepatocellular carcinoma complicated by major portal vein thrombosis, Oncology, 62, 69, 10.1159/000048279 Leung, 2002, Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy, Cancer, 94, 421, 10.1002/cncr.10236 Suou, 2001, Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C: a pilot study, Hepatol. Res., 20, 301, 10.1016/S1386-6346(00)00148-0 Klimpel, 1990, Virus-induced interferon alpha/beta (IFN-alpha/beta) production by T cells and by Th1 and Th2 helper T cell clones: a study of the immunoregulatory actions of IFN-gamma versus IFN-alpha/beta on functions of different T cell populations, Cell. Immunol., 128, 603, 10.1016/0008-8749(90)90052-S Darnell, 1994, Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins, Science, 264, 1415, 10.1126/science.8197455 Shuai, 1993, A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma, Science, 261, 1744, 10.1126/science.7690989 Meurs, 1990, Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon, Cell, 62, 379, 10.1016/0092-8674(90)90374-N Takaoka, 2003, Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence, Nature, 424, 516, 10.1038/nature01850 Gardner, 1993, Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase by G protein and tyrosine kinase oncoproteins, J. Biol. Chem., 268, 17896, 10.1016/S0021-9258(17)46789-5 Romerio, 2000, Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism, Br. J. Cancer, 83, 532, 10.1054/bjoc.2000.1263 Romerio, 2002, MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b, FASEB J., 16, 1680, 10.1096/fj.02-0120fje Moro, 2001, IFNalpha 2b induces apoptosis and proteasome-mediated degradation of p27Kip1 in a human lung cancer cell line, Oncol. Rep., 8, 425 Sangfelt, 1999, Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins, Oncogene, 18, 2798, 10.1038/sj.onc.1202609 Hovanessian, 1989, The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK, J. Interferon Res., 9, 641, 10.1089/jir.1989.9.641 Howe, 1992, Activation of the MAP kinase pathway by the protein kinase Raf, Cell, 71, 335, 10.1016/0092-8674(92)90361-F Kyriakis, 1992, Raf-1 activates MAP kinase-kinase, Nature, 358, 417, 10.1038/358417a0 Bromberg, 1996, Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma, Proc. Natl. Acad. Sci. U. S. A., 93, 7673, 10.1073/pnas.93.15.7673 Kaplan, 1998, Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice, Proc. Natl. Acad. Sci. U. S. A., 95, 7556, 10.1073/pnas.95.13.7556 Yano, 1999, Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines, Hepatology, 29, 1708, 10.1002/hep.510290624 Jia, 1997, Screening the p53 status of human cell lines using a yeast functional assay, Mol. Carcinog., 19, 243, 10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D Yu, 2004, Protein phosphatase 2A, a negative regulator of the ERK signaling pathway, is activated by tyrosine phosphorylation of putative HLA class II-associated protein I (PHAPI)/pp32 in response to the antiproliferative lectin, jacalin, J. Biol. Chem., 279, 41377, 10.1074/jbc.M400017200 Hwang, 2004, Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma, Hepatol. Res., 29, 113, 10.1016/j.hepres.2004.02.009 Cantley, 1991, Oncogenes and signal transduction, Cell, 64, 281, 10.1016/0092-8674(91)90639-G Pelech, 1992, MAP kinases: charting the regulatory pathways, Science, 257, 1355, 10.1126/science.1382311 McKillop, 1998, Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma, Hepatology, 26, 1484, 10.1002/hep.510260615 Ito, 1998, Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma, Hepatology, 27, 951, 10.1002/hep.510270409